2.4. Lysine Reduction not Only Reduced the Survival of EGFR-TKI-Resistant NSCLC Cells but Also Enhanced the Cytostatic Effect of the AKT Inhibitor and Osimertinib in EGFR-Mutant NSCLC Cells. This evidence concerns the gene EGFR and non-small cell lung carcinoma.